3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Frailty
12
Neoplasms
11
Ovarian Neoplasms
5
Lymphoma
5
Lung Neoplasms
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Lymphoma, Large B-Cell, Diffuse
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Treatment Adherence and Compliance
1
Stomach Neoplasms
1
Solid Neoplasm
1
Sarcopenia
1
Sarcoma
1
Recurrence
1
Prostate Cancer Cured
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Interventions
Cyclophosphamide
64
fludarabine phosphate
37
Peripheral Blood Stem Cell Transplantation
30
Cyclosporine
30
Radiotherapy
28
Mycophenolic Acid
28
Filgrastim
28
Busulfan
28
Whole-Body Irradiation
26
Antilymphocyte Serum
24
Melphalan
19
Etoposide
19
Tacrolimus
16
Methotrexate
16
Cord Blood Stem Cell Transplantation
16
Methylprednisolone
15
Rituximab
14
Thiotepa
10
Cytarabine
10
Vincristine
8
Prednisone
8
Doxorubicin
8
Carboplatin
7
fludarabine
5
Sirolimus
5
sargramostim
4
glofitamab
4
aldesleukin
4
Therapeutics
4
Leucovorin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Dendritic Cell Sarcoma, Interdigitating
×
Geriatric Assessment
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled